97925396 - ELEVIDYS

Information

  • Trademark
  • 97925396
  • Serial Number
    97925396
  • Filing Date
    May 08, 2023
    2 years ago
  • Transaction Date
    December 31, 2024
    4 months ago
  • Status Date
    December 31, 2024
    4 months ago
  • Published for Opposition Date
    November 19, 2024
    5 months ago
  • Location Date
    December 31, 2024
    4 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CHANG, BETTY
  • Attorney Name
    Maury M. Tepper, III
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
3
Mark Identification
ELEVIDYS
Case File Statements
  • DM0000: The mark consists of an oval shape comprised of three alternately-shaded curved bands increasing in size to an vesica piscis center and three alternately-shaded curved bands decreasing in size on the other side of the center and followed by "ELEVIDYS".
  • GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 5/11/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/6/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/7/2023 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 1/31/2024 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/23/2024 - a year ago
    9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 7/25/2024 - 9 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/31/2024 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/31/2024 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/31/2024 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/23/2024 - a year ago
    8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 7/25/2024 - 9 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/25/2024 - 9 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/2/2024 - 9 months ago
    14 - FINAL REFUSAL E-MAILED Type: GNFR
  • 8/2/2024 - 9 months ago
    15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/2/2024 - 9 months ago
    13 - FINAL REFUSAL WRITTEN Type: CNFR
  • 10/2/2024 - 7 months ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/2/2024 - 7 months ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/2/2024 - 7 months ago
    16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 10/9/2024 - 7 months ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/13/2024 - 6 months ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/19/2024 - 5 months ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/19/2024 - 5 months ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/31/2024 - 4 months ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM